A Phase l/ll trial of Trabedersen for pancreatic cancer.

Trial Profile

A Phase l/ll trial of Trabedersen for pancreatic cancer.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 27 Sep 2016

At a glance

  • Drugs Trabedersen (Primary)
  • Indications Pancreatic cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Sep 2016 New trial record
    • 02 Sep 2016 Results from this trial will be presented at the 43rd International Society of Oncology and Biomarkers (ISOBM) Congress 2016, as reported by an Oncotelic media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top